Alnylam Pharmaceuticals Stock Price on December 11, 2024

ALNY Stock  USD 254.15  0.24  0.09%   
If you're considering investing in Alnylam Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alnylam Pharmaceuticals stands at 254.15, as last reported on the 11th of December 2024, with the highest price reaching 255.92 and the lowest price hitting 250.21 during the day. Alnylam Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0112, which signifies that the company had a -0.0112% return per unit of risk over the last 3 months. Alnylam Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alnylam Pharmaceuticals' insignificant Risk Adjusted Performance, mean deviation of 1.42, and Standard Deviation of 2.11 to double-check the risk estimate we provide.
  
Alnylam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0112

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsALNY

Estimated Market Risk

 2.11
  actual daily
18
82% of assets are more volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Alnylam Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alnylam Pharmaceuticals by adding Alnylam Pharmaceuticals to a well-diversified portfolio.

Alnylam Pharmaceuticals Valuation on December 11, 2024

It is possible to determine the worth of Alnylam Pharmaceuticals on a given historical date. On December 11, 2024 Alnylam was worth 254.5 at the beginning of the trading date compared to the closed value of 254.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Alnylam Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Alnylam Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alnylam Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Alnylam Pharmaceuticals' related companies.
 Open High Low Close Volume
  257.72    257.99    250.33    253.91    447,171  
12/11/2024
  254.50    255.92    250.21    254.15    439,430  
Backtest Alnylam Pharmaceuticals  |  Alnylam Pharmaceuticals History  |  Alnylam Pharmaceuticals Valuation   Previous
Open Value
254.5
248.17
Downside
254.15
Closing Value
260.83
Upside

Alnylam Pharmaceuticals Trading Date Momentum on December 11, 2024

On December 11 2024 Alnylam Pharmaceuticals was traded for  254.15  at the closing time. The top price for the day was 255.92  and the lowest listed price was  250.21 . The trading volume for the day was 439.4 K. The trading history from December 11, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.14% .

Alnylam Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Alnylam Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Alnylam Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Alnylam financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Alnylam Pharmaceuticals Stock history

Alnylam Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alnylam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alnylam Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alnylam Pharmaceuticals stock prices may prove useful in developing a viable investing in Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. Alnylam Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1665 people.

Alnylam Pharmaceuticals Stock Technical Analysis

Alnylam Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Alnylam Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alnylam Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Alnylam Pharmaceuticals Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Alnylam Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Alnylam Pharmaceuticals December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Alnylam Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alnylam Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Alnylam Pharmaceuticals stock market strength indicators, traders can identify Alnylam Pharmaceuticals entry and exit signals to maximize returns

Alnylam Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Alnylam Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Alnylam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alnylam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Alnylam Stock Analysis

When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.